What is NDC 0069-0274?

0069-0274 is the product NDC for Velsipity (etrasimod), Etrasimod arginine 2 mg/1 tablet, film coated, listed with the FDA by Pfizer Laboratories Div Pfizer Inc. It has 1 package NDC, shown above in 10- and 11-digit form.

Pfizer Laboratories Div Pfizer Inc, NDC labeler code 0069. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Velsipity?

None: this is the only finished product listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Velsipity NDC 0069-0274 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)0069-0274Labeler and product segments. Claims need a package NDC.

Product NDC at billing width00069-0274Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
0069-0274-30	00069027430	1 BOTTLE in 1 CARTON (0069-0274-30) / 30 TABLET, FILM COATED in 1 BOTTLEMarketed from Oct 19, 2023

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Velsipity
Generic name (nonproprietary): etrasimod
Active ingredients: Etrasimod arginine — 2 mg/1
Dosage form: Tablet, Film coated
Route: Oral
Labeler: Pfizer Laboratories Div Pfizer IncNDC labeler code 0069
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 216956
Marketing start: Oct 19, 2023
Listing expires: Dec 31, 2026
Other FDA classes: Sphingosine 1-Phosphate Receptor Modulators (Mechanism)
Identifiers: Product ID 0069-0274_c2b3ca10-be3d-4c1c-b210-9ebefc065826SPL ID c2b3ca10-be3d-4c1c-b210-9ebefc065826SPL set ID 65171e4a-d136-4abc-b08c-c40c1b486ff6RxCUI 2668051, 2668057UNII MXE5EMA09L
Pharmacologic class: Sphingosine 1-phosphate Receptor Modulator

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N400069027430 followed by a unit qualifier and the quantity

Package 00069-0274-30. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Aug 18, 2025.

Indications (excerpt from the label)

VELSIPITY is indicated for the treatment of moderately to severely active ulcerative colitis (UC) in adults. VELSIPITY is a sphingosine 1-phosphate receptor modulator indicated for the treatment of moderately to severely active ulcerative colitis in adults. ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 0069-0274

What is NDC 0069-0274?: 0069-0274 is the product NDC for Velsipity (etrasimod), Etrasimod arginine 2 mg/1 tablet, film coated, listed with the FDA by Pfizer Laboratories Div Pfizer Inc. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Velsipity (Etrasimod).
What is the active ingredient?: Etrasimod arginine.
Who is the labeler?: Pfizer Laboratories Div Pfizer Inc, NDC labeler code 0069. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Velsipity?: None: this is the only finished product listed under this name.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Velsipity (Etrasimod) NDC 0069-0274